Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
AOD9604 caused only a modest weight increase, which was statistically significant only on the last day of the 14-day treatment period
The products available on this website are intended solely for in-vitro research purposes (Latin: in glass), meaning they are used in experiments conducted outside a living organism
Activity: Pair regular resistance and aerobic exercise with the protocol preclinical lean-mass effects were strongest when combined with exercise
Monitor for Results and Side Effects: Track changes in weight, body measurements, energy levels, and any adverse reactions
Semaglutide is a GLP-1 medication that reduces appetite, while AOD 9604 is a growth hormone fragment studied for fat metabolism
US$ 22.41
US$ 26.63
US$ 28.63
US$ 20.30
US$ 21.69
US$ 23.95
US$ 28.72
